Hong Kong Pharmaceuticals Stock News

CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh investor attention after China’s National Medical Products Administration approved satricabtagene autoleucel, the first CAR T-cell therapy cleared globally for a solid tumor indication. See our latest analysis for CARsgen Therapeutics Holdings. The satri-cel approval came after a mixed period for CARsgen Therapeutics Holdings. The 1-day share price return was 7.68%, while the 30-day share price return was down 21.81% and the 1-year...

China Taiping Insurance Holdings (SEHK:966) drew investor attention after shareholders at its AGM on 24 June 2026 approved a final dividend of HK$1.23 per share for the 2025 financial year. See our latest analysis for China Taiping Insurance Holdings. At a share price of HK$18.52, China Taiping Insurance Holdings has seen its 7 day share price return fall 10.88% and its 30 day share price return decline 6.79%, while the 1 year total shareholder return stands at 23.81% and the 3 year total...

Recent commentary on the aluminum extrusion market has highlighted projected growth in Asia Pacific, where United Company RUSAL International (SEHK:486) is a major producer serving construction and infrastructure demand across multiple regional end markets. See our latest analysis for United Company RUSAL International. Despite the supportive backdrop for aluminum extrusion demand, United Company RUSAL International’s share price has been weak. The stock is down 14.6% over 30 days and 35.8%...

Bank of China (SEHK:3988) has completed a RMB50b issuance of 10 year write down tier 2 capital bonds, a step that directly affects its capital structure, regulatory capital ratios, and long term funding mix. See our latest analysis for Bank of China. At a share price of HK$5.09, Bank of China has delivered a 12.36% year to date share price return, while its 1 year total shareholder return of 14.58% and very large 5 year total shareholder return point to momentum that has built steadily over...

Earlier this month, Ping An Healthcare and Technology upgraded its Ping An AI Doctor service, integrating the large‑model-powered tool across core Ping An apps to deliver rapid, AI-led consultations supervised throughout by licensed physicians and connected to an extensive online-to-offline healthcare network. On the same day, the company also announced the resignation of its long-serving CFO and board secretary, with experienced Ping An Group executive Qin Xu stepping in as CFO, joint...

Bright Smart Securities & Commodities Group earnings trigger fresh look at the stock Bright Smart Securities & Commodities Group (SEHK:1428) has just reported full year results to March 31, 2026, with revenue slightly lower year on year but higher net income and earnings per share. See our latest analysis for Bright Smart Securities & Commodities Group. Despite the improved full year profitability, Bright Smart Securities & Commodities Group’s share price has been under pressure, with a 30...

LFG Investment Holdings (SEHK:3938) has just released its FY 2026 numbers, with first half revenue of HK$33.1 million and basic EPS of HK$0.0069. This is set against trailing twelve month revenue of HK$79.7 million and basic EPS of HK$0.018 as the company moved into profit after earlier losses. Over the past few reporting halves, revenue has shifted from HK$7.3 million in 1H FY 2025 to HK$15.6 million in 2H FY 2025 and then to HK$33.1 million in 1H FY 2026. EPS went from a loss of HK$0.0431...

The fact that multiple FIT Hon Teng Limited ( HKG:6088 ) insiders offloaded a considerable amount of shares over the...

EuroEyes International Eye Clinic Limited ( HKG:1846 ) is about to trade ex-dividend in the next three days. The...

Datang Environment Industry Group Co., Ltd. ( HKG:1272 ) is about to trade ex-dividend in the next 3 days. The...

CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh investor attention after two drug developments in China, including approval of a quick dissolving albumin bound paclitaxel and regulatory acceptance of a new hypertension combination tablet. See our latest analysis for CSPC Pharmaceutical Group. Despite these clinical milestones, CSPC Pharmaceutical Group’s recent share price momentum has been weak, with the 30 day share price return down 10.8% and the year to date share price return down...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It looks like BOE Varitronix Limited ( HKG:710 ) is about to go ex-dividend in the next 3 days. The ex-dividend date is...

AV Concept Holdings (SEHK:595) has reported a punchy set of FY 2026 numbers, with first half revenue of HK$857.2 million and basic EPS of HK$0.0687. This is set against trailing 12 month revenue of HK$1.3 billion and EPS of HK$0.2551, which highlight the scale of its recent earnings profile. The company’s revenue has moved from HK$560.7 million in the second half of FY 2025 to HK$857.2 million in the first half of FY 2026. Over the same period, basic EPS shifted from a loss of HK$0.0029 per...

Emperor International Holdings (SEHK:163) has reported FY 2026 first half revenue of HK$1,569.2 million alongside a basic EPS loss of HK$0.42, keeping the focus firmly on how its income statement is holding up. Over recent periods the company has seen revenue move from HK$559.2 million in 1H FY 2025 to HK$1,001.3 million in 2H FY 2025 and HK$1,569.2 million in 1H FY 2026. Over the same intervals, losses expanded from HK$1,042.3 million to HK$1,278.6 million and then HK$2,290.6 million on a...

Pizu Group Holdings (SEHK:9893) has opened FY 2026 with first half revenue of C¥748.2 million and basic EPS of C¥0.030241, setting the tone for how investors read its latest results. Over the recent periods, the company has seen reported revenue move from C¥859.2 million and EPS of C¥0.024446 in 1H FY 2025 to C¥836.3 million and EPS of C¥0.022454 in 2H FY 2025, alongside trailing twelve month EPS of C¥0.052757 on revenue of C¥1.6 billion. This puts the focus squarely on how efficiently those...

Productive Technologies (SEHK:650) has just posted its FY 2026 results, with first half revenue of HK$77.6 million and a loss of HK$87.7 million, equivalent to basic EPS of HK$0.0119. Over the past three reported half year periods, the company has seen revenue move from HK$162.0 million in 1H FY 2025 to HK$116.8 million in 2H FY 2025 and HK$77.6 million in 1H FY 2026, while half year EPS shifted from HK$0.0217 to HK$0.0193 and then HK$0.0119, highlighting how the revenue base and per share...

KFM Kingdom Holdings (SEHK:3816) has put solid numbers on the table for FY 2026, with first half revenue of HK$459.5 million and basic EPS of HK$0.0498, set against trailing twelve month revenue of HK$1.0 billion and EPS of HK$0.1361 that came with earnings growth of 124.7% year over year. Over recent reporting periods, revenue has moved from HK$376.7 million in 1H FY 2025 to HK$380.8 million in 2H FY 2025 and then to HK$459.5 million in 1H FY 2026, while net income has shifted from HK$21.8...

Hong Kong Zcloud Technology Construction (SEHK:9900) has reported its FY 2026 results with first half revenue of HK$565.3 million and basic EPS of HK$0.001151, set against a trailing twelve month revenue base of HK$851.2 million and EPS of HK$0.0023. Over the past reported periods, the company recorded revenue of HK$620.6 million in 1H FY 2025 and HK$654.6 million in 2H FY 2025, while basic EPS moved from HK$0.005597 to HK$0.004836 across the same timeframe, which puts the latest numbers into...

As the Asian markets navigate a period of economic shifts and technological sell-offs, investors are increasingly seeking opportunities in lesser-known areas of the market. Penny stocks, though often considered a niche category, continue to offer potential growth prospects by focusing on smaller or newer companies with robust financial health. This article highlights three promising penny stocks that combine strong balance sheets with long-term potential, offering investors a chance to...

Bosideng International Holdings Limited has reported its full-year results for the 12 months ended March 31, 2026, with sales rising to CNY 27,349.98 million and net income reaching CNY 3,994.38 million. The improvement in both basic and diluted earnings per share from continuing operations suggests that Bosideng converted higher sales into stronger profitability over the year. We will now examine how Bosideng’s higher full-year earnings and improved profitability shape the company’s broader...

China’s push to expand offshore renminbi finance and reduce reliance on the US dollar is reshaping how capital flows through its banking and securities systems. For investors, that mix of reform, new liquidity tools, and rising geopolitical tension can mean fresh opportunities alongside new types of risk. This article looks at three stocks from an Emerging Market Financials screener that are closely exposed to these policy moves, focusing on how their roles in China and Hong Kong’s financial...

Recent Share Performance and Business Snapshot Geely Automobile Holdings (SEHK:175) has drawn attention after a period in which the stock declined over the past week, month, and past 3 months, prompting investors to reassess recent performance and fundamentals. The company, headquartered in Hong Kong and focused on passenger vehicles, parts, and electric mobility products under the ZEEKR brand, reports annual revenue of CN¥356,316.201 and net income of CN¥15,345.231. See our latest analysis...